Journal of Diabetes Research

Journal of Diabetes Research / 2020 / Article

Retraction | Open Access

Volume 2020 |Article ID 1013482 | https://doi.org/10.1155/2020/1013482

Journal of Diabetes Research, "Retracted: Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic β-Cell Mass in Middle-Aged Obese Diabetic Mice", Journal of Diabetes Research, vol. 2020, Article ID 1013482, 1 page, 2020. https://doi.org/10.1155/2020/1013482

Retracted: Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic β-Cell Mass in Middle-Aged Obese Diabetic Mice

Received11 Jul 2020
Accepted14 Jul 2020
Published29 Sep 2020

Journal of Diabetes Research has retracted the article titled “Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic β-Cell Mass in Middle-Aged Obese Diabetic Mice” [1]. As raised on PubPeer [2], the article was found to contain images with signs of manipulation.

In Figures 3(a) and 3(d), there is undeclared splicing in the Glut4 rows of the Western Blots. The original images are unavailable and the authors agreed to retraction.

References

  1. H. Alkhalidy, W. Moore, Y. Zhang et al., “Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic β-Cell Mass in Middle-Aged Obese Diabetic Mice,” Journal of Diabetes Research, vol. 2015, Article ID 532984, 14 pages, 2015. View at: Publisher Site | Google Scholar
  2. “Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic β-Cell Mass in Middle-Aged Obese Diabetic Mice,” March 2020: http://pubpeer.com/publications/AE77797DD9EADD05C93DD05607148A. View at: Google Scholar

Copyright © 2020 . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views86
Downloads34
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.